Effect of Antiplatelet Agents on Abdominal Aortic Aneurysm Process: A Systematic Review and Meta-Analysis [PDF]
Reviews in Cardiovascular Medicine, 2023 Background: This systematic review and meta-analysis aims to investigate whether antiplatelet agents are associated with the reduction, expansion, and rupture of abdominal aortic aneurysm (AAA).
Yang Yang +5 more
doaj +2 more sources
The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis
BMC Nephrology, 2020 Background The safety of antiplatelet therapy in haemodialysis (HD) patients remains controversial. we conducted the first meta-analysis to evaluate the bleeding risk with antiplatelet agents in these populations.
Qi Wang, Xiaojie Xie, Gaosi Xu
doaj +2 more sources
Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis. [PDF]
Ann Med, 2022 Background Serotonin reuptake inhibitor (SRI) antidepressants are implicated in increasing the risk of bleeding among users; however, the comparative increase in bleeding risk with concurrent antithrombotic therapy (anticoagulant or antiplatelet) remains
Nochaiwong S +9 more
europepmc +2 more sources
Hepatology Communications, 2018 Platelets participate in the development of liver fibrosis in animal models, but little is known about the benefit of antiplatelet agents in preventing liver fibrosis in humans.
Katharina Schwarzkopf +9 more
doaj +2 more sources
Association between osteoporosis or osteopenia and taking antiplatelet agents in general US population of NHANES [PDF]
Frontiers in Endocrinology, 2022 BackgroundOsteoporosis (OP) and osteopenia are common bone disorders in old age, and lots of patients suffering from OP or osteopenia need to take antiplatelet agents to treat basic diseases.
Hao Lv +7 more
doaj +2 more sources
COVID-19 mortality in patients on anticoagulants and antiplatelet agents. [PDF]
Br J Haematol, 2020 Coagulopathy (Tang, et al 2020) and a prothrombotic diathesis with high D-dimer and fibrinogen levels (Al-Samkari, et al 2020) are associated with coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Sivaloganathan H +2 more
europepmc +2 more sources
Concomitant Use of Antiplatelet Agents and Proton-Pump Inhibitors Increases the Risk of Adverse Cardiovascular Events: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions [PDF]
Journal of Cardiovascular Development and Disease, 2023 Antiplatelet agents are commonly used in combination with proton-pump inhibitors (PPIs) in patients with acute coronary syndrome who are at risk of gastrointestinal hemorrhage.
Hee Gyu Yang, Dong-Kyu Kim
doaj +2 more sources
The association of antiplatelet agents with mortality among patients with non–COVID-19 community-acquired pneumonia: a systematic review and meta-analysis [PDF]
Research and Practice in Thrombosis and HaemostasisBackground: Community-acquired pneumonia (CAP) triggers inflammatory and thrombotic host responses driving morbidity and mortality. Antiplatelet agents may favorably modulate these pathways; however, their role in non–COVID-19 CAP remains uncertain ...
Sylvain A. Lother +21 more
doaj +2 more sources
Association of antiplatelet agents and intracranial hemorrhage in geriatric emergency department patients with head trauma from a fall [PDF]
Trauma Surgery & Acute Care OpenBackground Older adults have the highest incidence of traumatic brain injury and are often on antiplatelet therapy. This study examines the association between preinjury antiplatelet agent use and intracranial hemorrhage in geriatric emergency department
Mike Wells +10 more
doaj +2 more sources
Editorial: Antiplatelet Agents in Stroke Prevention [PDF]
Frontiers in Neurology, 2021 Gergely Feher +5 more
doaj +2 more sources